Laboratory Corporation of America

Profile narrative

Laboratory Corporation of America, commonly known as LabCorp, is a United States-based healthcare diagnostics company. It provides clinical laboratory testing and diagnostic information used by physicians, hospitals, managed care organizations, employers, government entities, patients, and life sciences customers. Its work includes routine blood and specimen testing as well as specialized diagnostic areas such as pathology, molecular testing, genetic and genomic testing, oncology-related testing, infectious disease testing, and other esoteric laboratory services. LabCorp also supports drug testing operations and related testing services, including workplace and other non-clinical testing contexts. Through its diagnostics activities, it functions as a reference laboratory that receives specimens from healthcare providers and returns test results used in patient care.

LabCorp operates at a large national scale. The available context describes an extensive network linking numerous laboratories and medical facilities across the United States. Its scale is reflected in its position as a major U.S. blood testing and clinical diagnostics organization, with diagnostic processing and customer access to results forming an important part of its operations. The company’s footprint spans both patient-care diagnostics and services for the life sciences sector, placing it within both healthcare delivery and pharmaceutical development markets.

Structurally, LabCorp is associated with the Laboratory Corporation of America name and is commonly branded as LabCorp. Its business is commonly described through two major operating areas: LabCorp Diagnostics, which covers diagnostic testing and related services, and LabCorp Drug Development, which provides drug development and contract research services to biopharmaceutical and related customers. The Drug Development area grew from LabCorp’s acquisition of Covance, expanding the company’s role beyond clinical diagnostics into outsourced drug development support. A distinguishing feature of the organization is the combination of large-scale clinical testing, specialized diagnostic expertise, and life sciences services under one corporate umbrella. Its operations depend on laboratory information systems and connected infrastructure because diagnostic processing and customer access to results are central to its service model.

Incidents

1 incident linked to this organisation.